Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06411548 · ClinicalTrials.gov registry record · NA
InsuLearn Feasibility With Type 1 Diabetes Patients Under MDI Therapy
A NA study, sponsored by University of Virginia.
- Completed
- Registry status
- NA
- Development phase
- 7
- Enrollment target
NCT06411548 is a NA study that has completed, run by University of Virginia. The registered enrollment target is 7 participants.
The verdict
NCT06411548, a NA study, has completed, sponsored by University of Virginia.
- COMPLETED
- Registry status
- NA
- Development phase
- 7 participants
- Enrollment target
Study Summary
This is a 24-hour, randomized, crossover, single-center trial where participants are randomized to either start with the InsuLearn intervention or the usual care (UC) intervention. In the InsuLearn intervention, insulin doses are optimized using data collected in a 4-weeks at home data collection period.
Interventions
- DEVICE InsuLearn
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 7 participants |
| Start Date | 2025-03-27 |
| Est. Completion | 2025-10-17 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06411548
The ClinicalTrials.gov registry entry for NCT06411548 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 7 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Virginia, which has 449 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which InsuLearn is the first listed.
NCT06411548 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT06411548 about?
NCT06411548 is a clinical study titled "InsuLearn Feasibility With Type 1 Diabetes Patients Under MDI Therapy". This is a 24-hour, randomized, crossover, single-center trial where participants are randomized to either start with the InsuLearn intervention or the usual care (UC) intervention. In the InsuLearn intervention, insulin doses are optimized using data collected in a 4-weeks at home data collection pe...
What is the current status of trial NCT06411548?
This trial is currently completed. It is a NA study. The enrollment target is 7 participants. The study started on 2025-03-27. Estimated completion is 2025-10-17.
What interventions are being tested in trial NCT06411548?
The interventions under investigation include: InsuLearn (DEVICE).
Who is sponsoring clinical trial NCT06411548?
This trial is sponsored by University of Virginia, which has 449 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.